Thermo Fisher Scientific - TMO Forward P/S Multiple

Corporate company logo of Thermo Scientific (TMO)

Thermo Fisher Scientific (TMO) is optimizing its supply chains and services through third-party contractors. The company relies on a dedicated staff of engineers while selectively engaging genomics specialists. The defensive nature of the business ensures stability regardless of macro shocks. The forward P/S multiple clearly demonstrates this balance, fixing the metric at 3.80.

thermofisher.com - TMO Forward Price-to-Revenue Multiple (period 07/04/2022 - 11/17/2026)

Thermo Fisher (TMO) - metric breakdowns and financial figures

Summary company analysis:thermofisher.com TMO
Original product of thermofisher.com

Investors utilize this tool to verify the operational resilience of assets through the lens of market expectations. For Thermo Fisher Scientific (TMO), which scales its biotechnology ecosystem via acquisitions, revenue dynamics are critical. The forward P/S valuation metric compares current market capitalization with projected sales, enabling daily tracking of the market's reaction to business expansion and allowing for the assessment of the company's fundamental value between quarterly reports.